PlumX Metrics
Embed PlumX Metrics

Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2

Cancer Immunology, Immunotherapy, ISSN: 1432-0851, Vol: 72, Issue: 10, Page: 3243-3257
2023
  • 19
    Citations
  • 0
    Usage
  • 26
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Studies from Peking Union Medical College in the Area of Breast Cancer Described (Chimeric Antigen Receptor Macrophages Activated Through Tlr4 or Ifn-& Gamma; Receptors Suppress Breast Cancer Growth By Targeting Vegfr2)

2023 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Women's Health Daily -- Research findings on Oncology - Breast Cancer are

Article Description

Chimeric antigen receptor macrophage (CAR-M) is a promising immunotherapy strategy of anti-tumor due to its high infiltration, direct phagocytosis of tumor cells, immunomodulation of tumor microenvironment (TME) and linkage of innate and adaptive immunity. Here a series of novelly designed CAR-Ms by targeting vascular endothelial growth factor receptor-2 (VEGFR2), which highly expressed in tumor cells and TME, were evaluated. Their activation signals were transduced by Tlr4 or Ifn-γ receptors either alone or in combination, which were designed to mediate M1 polarization of macrophages as the downstream of lipopolysaccharide or Ifn-γ that had been widely reported. Our results showed that VEGFR2-targeting CAR-Ms could be activated under the stimulation of VEGFR2-expressing cells. They exhibited higher expression of CD86, MHCII and TNF-α in vitro and enhanced tumor suppressive abilities in vivo. Implantation of these CAR-Ms into 4T1 breast cancer-bearing mice could obviously inhibit the progression of tumor without significant toxic side effects, especially the group of mmC in which constructed with Tlr4 as the intracellular domain of CAR. In conclusion, this research provides a promising design of CAR that induce macrophages activation by Tlr4 and/or Ifn-γ receptors, and these CAR-Ms could effectively inhibit tumor growth through targeting VEGFR2.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know